Biomarkers in bronchiectasis

Bronchiectasis is a heterogeneous disease with multiple aetiologies and diverse clinical features. There is a general consensus that optimal treatment requires precision medicine approaches focused on specific treatable disease characteristics, known as treatable traits. Identifying subtypes of cond...

Full description

Bibliographic Details
Published in:	European Respiratory Review
Main Authors:	Emma Johnson, Merete B. Long, James D. Chalmers
Format:	Article
Language:	English
Published:	European Respiratory Society 2024-07-01
Online Access:	http://err.ersjournals.com/content/33/173/230234.full

Similar Items

Dipeptidyl peptidase-1 inhibitors in bronchiectasis
by: Emma Johnson, et al.
Published: (2025-06-01)

Management of Bronchiectasis in Adults
by: Mariana Conceição, et al.
Published: (2022-01-01)

Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management
by: Yunjoo Im, et al.
Published: (2025-01-01)

Get together to increase awareness in bronchiectasis: a report of the 2nd World Bronchiectasis Conference
by: Stefano Aliberti, et al.
Published: (2018-08-01)

Pathophysiology and genomics of bronchiectasis
by: Lidia Perea, et al.
Published: (2024-07-01)

Is bronchiectasis really a disease?
by: Michal Shteinberg, et al.
Published: (2020-01-01)

Predicting outcomes in bronchiectasis
by: M.A. Mendes, et al.
Published: (2018-05-01)

EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference
by: James D. Chalmers, et al.
Published: (2024-07-01)

Exacerbations of bronchiectasis
by: Alessandro De Angelis, et al.
Published: (2024-07-01)

Basic, translational and clinical aspects of bronchiectasis in adults
by: James D. Chalmers, et al.
Published: (2023-06-01)

Neutrophilic inflammation in bronchiectasis
by: James D. Chalmers, et al.
Published: (2025-04-01)

The Bronchiectasis Exacerbation Diary: a novel patient-reported outcome for non-cystic fibrosis bronchiectasis
by: Vivian H. Shih, et al.
Published: (2023-05-01)

Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis
by: Ravishankar Chandrasekaran, et al.
Published: (2018-05-01)

Bronchiectasis in Asia: a review of current status and challenges
by: Hayoung Choi, et al.
Published: (2024-09-01)

Endotypes in bronchiectasis: moving towards precision medicine. A narrative review
by: M. Martins, et al.
Published: (2023-11-01)

Short-term stability of the sputum microbiota in bronchiectasis and cystic fibrosis
by: Hollian Richardson, et al.
Published: (2025-06-01)

A systematic literature review of the clinical and socioeconomic burden of bronchiectasis
by: James D. Chalmers, et al.
Published: (2024-09-01)

Sputum procalcitonin: a potential biomarker in stable bronchiectasis
by: William Good, et al.
Published: (2021-10-01)

Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis
by: Mariana Conceição, et al.
Published: (2024-01-01)

Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial
by: James D. Chalmers, et al.
Published: (2019-05-01)

Benefit−risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis
by: James D. Chalmers, et al.
Published: (2023-05-01)

Safety profile of drugs used in non-cystic fibrosis bronchiectasis: a narrative review
by: Henil Upadhyay, et al.
Published: (2024-09-01)

Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey
by: Michal Shteinberg, et al.
Published: (2024-01-01)

Bronchiectasis
by: Beatriz Raboso, et al.
Published: (2024-07-01)

Prediction of Clinical Bronchiectasis from Asymptomatic Radiological Bronchiectasis
by: Fan Y, et al.
Published: (2025-04-01)

Brensocatib in patients with bronchiectasis: subgroup analyses from the WILLOW trial
by: James D. Chalmers, et al.
Published: (2025-01-01)

Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics
by: James D. Chalmers, et al.
Published: (2024-07-01)

Insights into respiratory microbiome composition and systemic inflammatory biomarkers of bronchiectasis patients
by: Aleksandras Konovalovas, et al.
Published: (2024-12-01)

Metabolomics identify serum biomarkers for predicting acute exacerbation and severity of bronchiectasis
by: Jiaxin Yan, et al.
Published: (2025-03-01)

Bronchiectasis in pediatrics
by: Laura Garriga-Grimau, et al.
Published: (2025-01-01)

Epidemiology of bronchiectasis
by: Mattia Nigro, et al.
Published: (2024-10-01)

The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasis
by: J.C. Costa, et al.
Published: (2018-05-01)

The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasis
by: J.C. Costa, et al.
Published: (2018-05-01)

Epidemiological aspects in bronchiectasis
by: Gabriela C.OBILIŞTEANU, et al.
Published: (2016-09-01)

Dual Bronchodilators in Bronchiectasis Study: a randomised controlled trial
by: Nina Wilson, et al.
Published: (2025-06-01)

Scimitar syndrome, bronchiectasis, haemoptysis and a pneumonectomy
by: Emma Jeffs, et al.
Published: (2024-01-01)

Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis
by: Martina Contarini, et al.
Published: (2018-08-01)

Automated method of bronchus and artery dimension measurement in an adult bronchiectasis population
by: Angelina L.P. Pieters, et al.
Published: (2024-12-01)

Carcinoid tumour behind bronchiectasis
by: N. Charokopos, et al.
Published: (2016-02-01)

Bronchiectasis-associated infections and outcomes in a large, geographically diverse electronic health record cohort in the United States
by: Samantha G Dean, et al.
Published: (2024-04-01)